Novavax Inc (NVAX)
$7.13
0.32 (4.70%)
NVAX Stock Quote Delayed 30 Minutes
7 Biotech Stocks to Sell in September Before They Crash & Burn
Biotech stocks to sell are a dime a dozen and very risky which is why September is a great time to offload them.
11 Best Stocks to Buy for 2023
INSIDE: Investing legend Louis Navellier reveals his Top 11 Stocks for 2023 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
531.07M
PE Ratio
-0.98
EPS
-7.28
Volume (Avg. Vol.)
6.60M
Day's Range
$6.81 - $7.16
52-Week Range
$5.61 - $25.66
Dividend & Yield
N/A (N/A)
NVAX Stock Predictions, Articles, and Novavax Inc News
7 Very Oversold Nasdaq Stocks to Buy Right Now
The worries that have pushed the Nasdaq down sharply are overdone. Here are seven oversold Nasdaq stocks poised to rebound.
Novavax (NVAX) Stock Is Getting Ready to Rally Again
Novavax only has an Emergency Use Authorization and faces a struggle to get paid for its protein-based Covid shot.
Why Is Novavax (NVAX) Stock Up 15% Today?
Investors in Novavax have had a very rough go over the past two years, but NVAX stock is rebounding nicely today.
Novavax (NVAX) Stock Gets a Boost From Q2 Vaccine Sales
Novavax (NVAX) stock is climbing higher on Tuesday after the vaccine company released earnings results for the second quarter of the year.
Why Is Novavax (NVAX) Up 30% Today?
While Novavax secured an agreement with the Canadian government over unused Covid-19 vaccines, NVAX stock remains risky.
3 Pharma Stocks That Have Big Investors Running for the Exit
Hedge funds, institutional investors and company insiders have been dumping shares of these risky pharma stocks.
Exit Strategy: Get Out of These 3 Poor-Performing Stocks Now
Avoiding bad investments is just as important as spotting good opportunities, so watch out for these stocks to sell now.
Artificial Intelligence Engine Predicts NVAX Stock to Gain 7% by June 15
Watch our new video to find out how you can get 3,000 more predictions just like this
Short-Squeeze Stocks Alert: CVNA, NVAX Make Most-Shorted Stocks List
Business news outlet CNBC recently posted its list of top short-squeeze stocks, which present potentially lucrative though risky ideas.
Novavax Layoffs 2023: What to Know About the Latest NVAX Job Cuts
Novavax (NVAX) layoffs are on the way as the vaccine maker revealed plans to cut a large portion of its workforce on Tuesday!
